Tharimmune, Inc. (CNTN)

Market Cap	195.67M
Revenue (ttm)	n/a
Net Income	-10.32M
EPS	-3.05
Shares Out	39.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,005,243
Open	4.750
Previous Close	4.740
Day's Range	4.740 - 5.160
52-Week Range	0.952 - 9.080
Beta	1.45
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 23, 2026

About CNTN

Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.

• Founded: 2017
• Employees: 3
• Stock Exchange: NASDAQ
• Ticker Symbol: CNTN
• Website: https://www.tharimmune.com